ARTICLE | Company News
BioChem deal
February 14, 1994 8:00 AM UTC
The Laval, Quebec, company and Glaxo Canada Inc. extended their antiviral research agreement for two years to Dec. 31, 1996. The extension will allow the partners to further develop antivirals to treat herpes, hepatitis C and cytomegalovirus. ...